Filing Details
- Accession Number:
- 0001437749-17-006188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-05 21:15:56
- Reporting Period:
- 2017-04-03
- Filing Date:
- 2017-04-05
- Accepted Time:
- 2017-04-05 21:15:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1162461 | Cutera Inc | CUTR | Electromedical & Electrotherapeutic Apparatus (3845) | 770492262 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697417 | Miguel Pardos | C/O Cutera, Inc. 3240 Bayshore Blvd Brisbane CA 94005 | Evp, International Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common | Acquisiton | 2017-04-03 | 5,000 | $9.97 | 44,698 | No | 4 | M | Direct | |
| Common | Disposition | 2017-04-03 | 5,000 | $20.73 | 39,698 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Commmon Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-04-03 | 5,000 | $0.00 | 70,000 | $9.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 45,000 | 2015-09-11 | 2021-07-25 | No | 4 | M | Direct |
Footnotes
- Stock sold pursuant to a 10b5-1 trading plan. Stock prices ranged from $20.65 to $20.80, with $20.726 being the average. The reporting person undertakes to provide to Cutera, Inc., any security holder of Cutera, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
